日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes

无需输血的时间：一种以患者为中心的新型指标，用于评估骨髓增生异常综合征的新疗法

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2022.281856
Zeidner, Joshua F; Mazerolle, Flora; Norton, Jonathan; Regnault, Antoine; Kristo, Fjoralba; Romero, Heather; Fram, Robert J; Faller, Douglas V; Dalal, Mehul; Ades, Lionel; Sekeres, Mikkael A
发表日期：2023
文献求助 收藏

Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study

纳那替诺司他联合缬更昔洛韦靶向治疗复发性EBV阳性淋巴瘤：一项1b/2期研究

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2023010330
Haverkos, Bradley; Alpdogan, Onder; Baiocchi, Robert; Brammer, Jonathan E; Feldman, Tatyana A; Capra, Marcelo; Brem, Elizabeth A; Nair, Santosh; Scheinberg, Phillip; Pereira, Juliana; Shune, Leyla; Joffe, Erel; Young, Patricia; Spruill, Susan; Katkov, Afton; McRae, Robert; Royston, Ivor; Faller, Douglas V; Rojkjaer, Lisa; Porcu, Pierluigi
淋巴瘤
发表日期：2023
文献求助 收藏

A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer

一项随机 II 期研究，比较 sapanisertib 联合紫杉醇与单用紫杉醇治疗晚期、复发性或持续性子宫内膜癌女性患者的疗效。

期刊:Gynecologic Oncology
影响因子:4.1
doi:10.1016/j.ygyno.2023.09.013
Han, Sileny N; Oza, Amit; Colombo, Nicoletta; Oaknin, Ana; Raspagliesi, Francesco; Wenham, Robert M; Braicu, Elena Ioana; Jewell, Andrea; Makker, Vicky; Krell, Jonathan; Alía, Eva María Guerra; Baurain, Jean-François; Su, Zhenqiang; Neuwirth, Rachel; Vincent, Sylvie; Sedarati, Farhad; Faller, Douglas V; Scambia, Giovanni
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Pevonedistat in East Asian patients with acute myeloid leukemia or myelodysplastic syndromes: a phase 1/1b study to evaluate safety, pharmacokinetics and activity as a single agent and in combination with azacitidine

在东亚急性髓系白血病或骨髓增生异常综合征患者中评估培沃地司他单药及联合阿扎胞苷治疗的安全性、药代动力学和活性的1/1b期研究

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-022-01264-w
Handa, Hiroshi; Cheong, June-Won; Onishi, Yasushi; Iida, Hiroatsu; Kobayashi, Yukio; Kim, Hyeoung-Joon; Chiou, Tzeon-Jye; Izutsu, Koji; Tsukurov, Olga; Zhou, Xiaofei; Faessel, Helene; Yuan, Ying; Sedarati, Farhad; Faller, Douglas V; Kimura, Akiko; Wu, Shang-Ju
白血病
发表日期：2022
文献求助 收藏

A randomized phase 3 study of ixazomib-dexamethasone versus physician's choice in relapsed or refractory AL amyloidosis

一项随机3期研究，比较伊沙佐米-地塞米松与医生选择的方案治疗复发或难治性AL淀粉样变性。

期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-021-01317-y
Dispenzieri, Angela; Kastritis, Efstathios; Wechalekar, Ashutosh D; Schönland, Stefan O; Kim, Kihyun; Sanchorawala, Vaishali; Landau, Heather J; Kwok, Fiona; Suzuki, Kenshi; Comenzo, Raymond L; Berg, Deborah; Liu, Guohui; Kumar, Arun; Faller, Douglas V; Merlini, Giampaolo
发表日期：2022
文献求助 收藏

A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies

Sapanisertib (TAK-228) 在东亚晚期非血液系统恶性肿瘤患者中的 I 期研究

期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-021-00855-w
Shimizu, Toshio; Kuboki, Yasutoshi; Lin, Chia-Chi; Yonemori, Kan; Yanai, Tomoko; Faller, Douglas V; Dobler, Lwona; Gupta, Neeraj; Sedarati, Farhad; Kim, Kyu-Pyo
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Correction to: A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies

更正：一项针对东亚晚期非血液系统恶性肿瘤患者的Sapanisertib (TAK-228) 1期研究

期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-022-00881-2
Shimizu, Toshio; Kuboki, Yasutoshi; Lin, Chia-Chi; Yonemori, Kan; Yanai, Tomoko; Faller, Douglas V; Dobler, Lwona; Gupta, Neeraj; Sedarati, Farhad; Kim, Kyu-Pyo
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Global epidemiology of amyloid light-chain amyloidosis

全球淀粉样轻链淀粉样变性流行病学

期刊:Orphanet Journal of Rare Diseases
影响因子:3.5
doi:10.1186/s13023-022-02414-6
Kumar, Nishant; Zhang, Nicole J; Cherepanov, Dasha; Romanus, Dorothy; Hughes, Michael; Faller, Douglas V
发表日期：2022
文献求助 收藏

Phase 1 study to evaluate the effects of rifampin on pharmacokinetics of pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors

一项评估利福平对晚期实体瘤患者体内 NEDD8 激活酶抑制剂 pevonedistat 药代动力学影响的 1 期研究

期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-022-01286-8
Zhou, Xiaofei; Vaishampayan, Ulka; Mahalingam, Devalingam; Harvey, R Donald; Chung, Ki Young; Sedarati, Farhad; Dong, Cassie; Faller, Douglas V; Venkatakrishnan, Karthik; Gupta, Neeraj
发表日期：2022
文献求助 收藏

Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30

采用基于 EORTC QLQ-C30 的模块化方法测量骨髓增生异常综合征患者自述的身体功能和疲劳程度

期刊:Journal of Patient-Reported Outcomes
影响因子:2.9
doi:10.1186/s41687-021-00334-w
Regnault, Antoine; Pompilus, Farrah; Ciesluk, Anna; Mazerolle, Flora; Bejar, Rafael; Fram, Robert J; Faller, Douglas V; Marquis, Patrick; Bell, Jill A
发表日期：2021
文献求助 收藏